HEALTH PROPERTIES AND THERAPEUTIC POTENTIAL OF YERBA MATE (ILEX PARAGUARIENSIS) IN HEALTHCARE: A COMPREHENSIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.4730Keywords:
Yerba Mate, Ilex Paraguariensis, Polyphenols, Antioxidant, Anti-Inflammatory, Metabolic Health, Functional FoodAbstract
Yerba mate (Ilex paraguariensis) has emerged as a promising nutraceutical with pleiotropic metabolic and immunomodulatory effects relevant to cardiovascular risk modification, obesity care, glycemic control, oxidative stress, gut immune homeostasis, and inflammatory bowel disease. Randomized clinical data demonstrate reductions in body fat mass, percent body fat, and waist–hip ratio without safety concerns after 12 weeks of standardized supplementation, aligning with mechanistic rodent work showing tissuespecific bioenergetic reprogramming, antiinflammatory signaling, improved mitochondrial coupling in muscle, adipose thermogenic uncoupling, and enhanced hepatic redox tone. Metaanalytic evidence on lipids remains inconclusive overall, though individual trials report favorable LDLC signals in dyslipidemia, including addon effects to statins. Preclinical and translational studies indicate attenuation of hypothalamic and adipose inflammation, improved insulin signaling via PI3K–AKT pathways, modulation of macrophage polarization toward M2 phenotypes, and microbiota shifts that may augment metabolic and intestinal antiinflammatory activity. Safety signals are generally favorable when consumed in moderate amounts, with attention to preparation practices to minimize polycyclic aromatic hydrocarbons and to manganese intake with very high volume use. This narrative synthesizes clinically salient evidence and proposes patient-oriented use of yerba mate in cardiometabolic risk reduction, weight management, and adjunctive care in colitis, while outlining dosing, formulation, and monitoring considerations and research priorities.
References
Bremer Boaventura, B. C., da Silva, E. L., Liu, R. H., Prudêncio, E. S., Di Pietro, P. F., Becker, A. M., et al. (2015). Effect of yerba mate (Ilex paraguariensis A. St. Hil.) infusion obtained by freeze concentration technology on antioxidant status of healthy individuals. LWT - Food Science and Technology, 62, 948–954. https://doi.org/10.1016/j.lwt.2015.02.028
Conceição, E. P. S., Kaezer, A. R., Peixoto-Silva, N., Felzenszwalb, I., de Oliveira, E., Moura, E. G., et al. (2017). Effects of Ilex paraguariensis (yerba mate) on the hypothalamic signalling of insulin and leptin and liver dysfunction in adult rats overfed during lactation. Journal of Developmental Origins of Health and Disease, 8, 123–132. https://doi.org/10.1017/S2040174416000519
Gambero, A., & Ribeiro, M. L. (2015). The positive effects of yerba maté (Ilex paraguariensis) in obesity. Nutrients, 7, 730–750. https://doi.org/10.3390/nu7020730
Heck, C. I., & de Mejia, E. G. (2007). Yerba mate tea (Ilex paraguariensis): A comprehensive review on chemistry, health implications, and technological considerations. Journal of Food Science, 72, R138–R151. https://doi.org/10.1111/j.1750-3841.2007.00535.x
Hussein, G. M. E., Matsuda, H., Nakamura, S., Hamao, M., Akiyama, T., Tamura, K., et al. (2011). Mate tea (Ilex paraguariensis) promotes satiety and body weight lowering in mice: Involvement of glucagon-like peptide-1. Biological & Pharmaceutical Bulletin, 34, 1849–1855. https://doi.org/10.1248/bpb.34.1849
Kim, S.-Y., Oh, M.-R., Kim, M.-G., Chae, H.-J., & Chae, S.-W. (2015). Anti-obesity effects of yerba mate (Ilex paraguariensis): A randomized, double-blind, placebo-controlled clinical trial. BMC Complementary and Alternative Medicine, 15, 338. https://doi.org/10.1186/s12906-015-0859-1
Mateos, R., Baeza, G., Sarriá, B., & Bravo, L. (2018). Improved LC-MSn characterization of hydroxycinnamic acid derivatives and flavonols in different commercial mate (Ilex paraguariensis) brands: Quantification of polyphenols, methylxanthines, and antioxidant activity. Food Chemistry, 241, 232–241. https://doi.org/10.1016/j.foodchem.2017.08.085
Meinhart, A. D., Caldeirão, L., Damin, F. M., Filho, J. T., & Godoy, H. T. (2018). Analysis of chlorogenic acids isomers and caffeic acid in 89 herbal infusions (tea). Journal of Food Composition and Analysis, 73, 76–82. https://doi.org/10.1016/j.jfca.2018.08.001
de Morais, E. C., Stefanuto, A., Klein, G. A., Boaventura, B. C. B., de Andrade, F., Wazlawik, E., et al. (2009). Consumption of yerba mate (Ilex paraguariensis) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL-cholesterol reduction in individuals on statin therapy. Journal of Agricultural and Food Chemistry, 57, 8316–8324. https://doi.org/10.1021/jf901660g
Olate-Briones, A., Albornoz-Muñoz, S., Rodríguez-Arriaza, F., Rodríguez-Vergara, V., Aguirre, J. M., Liu, C., et al. (2024). Yerba mate (Ilex paraguariensis) reduces colitis severity by promoting anti-inflammatory macrophage polarization. Nutrients, 16, 1616. https://doi.org/10.3390/nu16111616
Rząsa-Duran, E., Kryczyk-Poprawa, A., Drabicki, D., Podkowa, A., Sułkowska-Ziaja, K., Szewczyk, A., et al. (2022). Yerba mate as a source of elements and bioactive compounds with antioxidant activity. Antioxidants, 11, 371. https://doi.org/10.3390/antiox11020371
Santos, D., Frota, E. G., Vargas, B. K., Tonieto Gris, C. C., Santos, L. F. D., & Bertolin, T. E. (2022). What is the role of phenolic compounds of yerba mate (Ilex paraguariensis) in gut microbiota? Phytochemistry, 203, 113341. https://doi.org/10.1016/j.phytochem.2022.113341
Walton, C. M., Saito, E. R., Warren, C. E., Larsen, J. G., Remund, N. P., Reynolds, P. R., et al. (2023). Yerba maté (Ilex paraguariensis) supplement exerts beneficial, tissue-specific effects on mitochondrial efficiency and redox status in healthy adult mice. Nutrients, 15, 4454. https://doi.org/10.3390/nu15204454
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Aleksandra Trojańska, Karol Śliwa, Anita Pieńkowska, Paulina Malon, Nel Geworkian, Natalia Hariasz, Martyna Pietz, Anita Szymańska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
